Ryvivyr
RyvivyR is developing advanced statistical models and machine learning algorithms to personalize neurostimulation treatments for neurological disorders. Their proprietary software integrates with existing devices to modulate stimulus in real-time based on neural activity, aiming to improve patient outcomes for conditions like depression, OCD, and Parkinson's disease. The company also offers solutions for Disorders of Consciousness, neuro drug discovery by identifying biomarkers, and research tools for understanding neural dynamics. Their 'Escape-the-Maze' algorithm has shown potential for a 50% increase in efficacy and is 6x faster than alternatives. RyvivyR targets the over $40 billion neurostimulation market with its AI-driven, hardware-agnostic approach, differentiating itself from legacy MedTech companies.
Ryvivyr
RyvivyR is developing advanced statistical models and machine learning algorithms to personalize neurostimulation treatments for neurological disorders. Their proprietary software integrates with existing devices to modulate stimulus in real-time based on neural activity, aiming to improve patient outcomes for conditions like depression, OCD, and Parkinson's disease. The company also offers solutions for Disorders of Consciousness, neuro drug discovery by identifying biomarkers, and research tools for understanding neural dynamics. Their 'Escape-the-Maze' algorithm has shown potential for a 50% increase in efficacy and is 6x faster than alternatives. RyvivyR targets the over $40 billion neurostimulation market with its AI-driven, hardware-agnostic approach, differentiating itself from legacy MedTech companies.